Site-Sponsor Consortium

Building shared industry standards through collaboration

The Site-Sponsor Consortium is an invitation-only forum that brings together influential leaders from sponsors, sites, and CROs to reduce clinical trial complexity, streamline study startup, and accelerate the path to patient therapies.

Industry leaders share why they joined the Consortium, what they hope to achieve, and some of the benefits from their first initiative as a collective: streamlining CDAs.

Industry Report: CDA Guidance and Template

Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements and Processes

The Site-Sponsor Consortium’s inaugural deliverable tackles an early bottleneck in study startup: the Confidential Disclosure Agreement (CDA). This industry report outlines why CDAs should remain simple and mutual, how to avoid common pitfalls, and when a master CDA removes rework—so study feasibility can begin sooner. The companion Master Mutual CDA Template turns guidance into action, paving a faster and simpler path to feasibility assessments, site selection, and startup planning.

Our vision

A future where sites, CROs, and sponsors work together seamlessly, fostering innovation, reducing complexities, and bringing life-changing treatments to patients faster.

Our mission

To expedite clinical research today by co-creating vendor-agnostic deliverables that drive progress, strengthen collaboration, and dismantle operational silos—fostered through an environment of open dialogue, shared knowledge, and strategic innovation.

Members

Jamie Bendrick-Peart

Senior Director, Innovation & Strategic Projects
AstraZeneca

Kyle Bird

VP, Clinical Research
Dana-Farber Harvard Cancer Center

Christina Brennan, MD

SVP, Clinical Research
Northwell Health

Jennifer Byrne

Chief Executive Officer
Javara Research

Kari Delahunty

Chief Executive Officer
AMR Clinical

Nicholas Fisher

Executive Director, Research & Business Administration
Alvin J. Siteman Cancer Center at Washington University School of Medicine & Barnes Jewish Hospital

Patrick Floody

VP, Global Clinical Trial Services
Regeneron

Tamara Hughes

SVP, Study Start-Up and Site Activation
ICON

Alison Liddy

SVP, Patient & Site Centric Solutions
IQVIA

Carly Lovelett

Associate Director, Protocol Activation & Lifecycle Management (PALM)
Yale Center for Clinical Investigation

Karen McIntyre

VP, Global Site Alliances
Parexel

Kristie Moffett

Senior Director, Human Subjects Research
Moffitt Cancer Center

Timothy Mudric

VP, Clinical Development Strategy Enablement
PPD, part of Thermo Fisher Scientific

Emilio Neto

Global Head of Country & Site Operations
Biogen

Carlos Orantes

Chief Executive Officer
Alcanza Clinical Research

Marisa Rackley

VP, Study Optimization, Clinical Site Startup & Site Engagement
Takeda

Michelle Rowe

Vice President
HCA Healthcare Research

Christine Senn

SVP, Site-Sponsor Innovation; Chair, Site-Sponsor Consortium
Advarra

Nick Spittal

Chief Operations Officer
Velocity Clinical Research

Brandi Walker

EVP, Global Clinical Operations
Syneos Health

Ian Wyglednowski

VP, Global Head of Strategic Clinical Partnering
UCB

“Our strategic relationships with sites, life sciences companies, and CROs put Advarra in a unique position to bring together leaders in the industry, meeting this challenge head-on and building a site-centric, connected ecosystem.”

Christine Senn SVP, Site-Sponsor Innovation, Advarra and Chair of the Site-Sponsor Consortium

Shaping the future of clinical research

The consortium is built on three core pillars:

Persistent progress

We develop and drive standards that scale beyond our organizations, benefitting
the entire industry.

Seamless workflows

We align processes across the clinical trial lifecycle—from protocol design through study execution and closeout—to reduce redundancies, speed feasibility, and improve predictability.

Open access

Transparency is in our DNA: We make solutions and best practices publicly available to all, so sponsors, CROs, and sites can remove unnecessary complexity and advance trials responsibly.

Working together to change clinical research

The Site-Sponsor Consortium aims to streamline the processes currently hampering clinical research by integrating sponsor, CRO, and site workflows, reducing administrative burdens, and allowing sites to focus on what matters most — patient care.

Sponsors

The Consortium works toward faster study startup, a central platform for site oversight and communication, reduced activation timelines, and higher data quality through seamless site communication.

Sites

The Consortium works toward reduced administrative burden, less duplication of efforts, improved centralized document and resource management, and a stronger voice in how trials operate.

Participants

The Consortium works toward improved experiences, more time with site staff, and better resources, all leading to more successful trials.

Subscribe to stay informed

Receive quarterly updates on product developments, meetings, and progress.